spesolimab
Showing 1 - 16 of 16
Pyoderma Gangrenosum Trial in New York (Spesolimab)
Recruiting
- Pyoderma Gangrenosum
- Spesolimab
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 16, 2023
Generalized Pustular Psoriasis Trial (Spesolimab)
Not yet recruiting
- Generalized Pustular Psoriasis
- Spesolimab
- (no location specified)
Sep 4, 2023
PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms
Not yet recruiting
- Generalized Pustular Psoriasis
- Spesolimab
- (no location specified)
Jan 2, 2023
Crohn Disease Trial in Worldwide (Spesolimab)
Completed
- Crohn Disease
- Spesolimab
-
Wien, Austria
- +6 more
Oct 4, 2022
Generalized Pustular Psoriasis Trial in China (spesolimab)
Recruiting
- Generalized Pustular Psoriasis
- spesolimab
-
Beijing, China
- +10 more
Jan 23, 2023
Hidradenitis Suppurativa Trial in Worldwide (Spesolimab)
Active, not recruiting
- Hidradenitis Suppurativa
- Spesolimab
-
Los Angeles, California
- +20 more
Jan 9, 2023
Generalized Pustular Psoriasis Trial in Japan (spesolimab)
Recruiting
- Generalized Pustular Psoriasis
- spesolimab
-
Aichi, Nagoya, Japan
- +12 more
Aug 10, 2022
Fibrostenotic Crohn´s Disease Trial in Worldwide (Spesolimab, Placebo)
Terminated
- Fibrostenotic Crohn´s Disease
- Spesolimab
- Placebo
-
Saint Louis, Missouri
- +13 more
Jun 20, 2022
Hidradenitis Suppurativa Trial in Worldwide (Spesolimab, Placebo)
Completed
- Hidradenitis Suppurativa
- Spesolimab
- Placebo
-
Los Angeles, California
- +24 more
Sep 13, 2022
Palmoplantar Pustulosis Trial in Worldwide (Spesolimab)
Recruiting
- Palmoplantar Pustulosis
- Spesolimab
-
Birmingham, Alabama
- +65 more
Aug 9, 2022
Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab, Placebo)
Completed
- Generalized Pustular Psoriasis
- Spesolimab
- Placebo
-
Birmingham, Alabama
- +36 more
Feb 11, 2022
Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab)
Recruiting
- Generalized Pustular Psoriasis
- Spesolimab
-
Auburn Hills, Michigan
- +49 more
Aug 22, 2022
Healthy Trial in Antwerpen (Spesolimab)
Completed
- Healthy
- Spesolimab
-
Antwerpen, BelgiumSGS Life Science Services - Clinical Research
Sep 11, 2019